开始
warrenhochfeld

KERX bull run ahead of Auryxia label extension

做多
warrenhochfeld  
NASDAQ:KERX   None
Trend Analysis Beyond Technical Analysis KERX
2
0
trendanalysis beyondta kerx
Label Expansion Opportunity: seeking approval of Auryxia for the treatment of patients with iron deficiency anemia and non-dialysis dependent chronic kidney disease
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。